E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor-Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)
Roisin M Connolly; Fengmin Zhao; Kathy D Miller; Min-Jung Lee; Richard L Piekarz; Karen L Smith; Ursa A Brown-Glaberman; Jennifer S Winn; Bryan A Faller; Adedayo A Onitilo; Mark E Burkard; George T Budd; Ellis G Levine; Melanie E Royce; Peter A Kaufman; Alexandra Thomas; Jane B Trepel; Antonio C Wolff; Joseph A Sparano